ERBB2 and breast cancer: Stratifying into molecular subgroups, we showed a significant favorable prognostic effect of TGIF expression on DFS in ER-positive and HER2-negative tumors and, consequently, in non-TNBC cases in univariate analysis with significant interaction only for HER2-negative BC subgroup.